Dexmedetomidine reduces anesthesia needs in pediatric dental surgery :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Dexmedetomidine lowers Propofol and Remifentanil use in pediatric dental surgery

Dental surgery Dental surgery
Dental surgery Dental surgery

What's new?

A single postinduction bolus of Dexmedetomidine at 1 mcg/kg markedly reduces the need for Propofol and Remifentanil during pediatric anesthesia, enhancing both safety and efficacy.

As per the outcomes of a recent study in children (aged 2–10 years) undergoing dental surgery, administering a postinduction bolus of 1 mcg/kg Dexmedetomidine was linked with a reduction in the Propofol (−10.0%) and Remifentanil (−13.7%) requirements for maintaining anesthesia. While Dexmedetomidine, an α2-adrenergic agonist, has been shown to lower anesthesia requirements in adults, its effects in children have not been extensively studied. Hence, this research investigated its potential to optimize anesthetic management during pediatric surgeries, marking a promising advancement in pediatric anesthesia practices.

In this double-blind, randomized controlled trial, children undergoing elective dental surgery were divided into four groups: placebo, 0.25 mcg/kg, 0.5 mcg/kg, and 1 mcg/kg Dexmedetomidine. Total intravenous anesthesia was maintained utilizing a fixed ratio of Propofol and Remifentanil, following a bispectral index-guided algorithm to achieve stable anesthetic depth. The primary outcomes were the maintenance infusion rates of both drugs, while secondary outcomes included sedation scores, pain scores, and discharge times.

Analysis was conducted on data from 67 patients.  Using Dexmedetomidine 1 mcg/kg resulted in considerably lower infusion rates for both Propofol and Remifentanil compared to placebo, with reductions of 10.0% and 13.7%, respectively. These findings were statistically significant, demonstrating reduced anesthesia requirements in the Dexmedetomidine group, as shown in Table 1:

 

However, lower doses (0.25 and 0.5 mcg/kg) did not show pivotal differences. No notable changes in pain or sedation scores, or discharge times, were observed. Hence, 1 mcg/kg Dexmedetomidine appears to be a promising anesthetic-sparing agent during total intravenous anesthesia for pediatric dental surgery. This drug-sparing effect may be valuable in clinical settings for short, stimulating procedures and can support the application of total intravenous anesthesia with spontaneous respiration.

Source:

Pediatric Anesthesia

Article:

Anesthetic-sparing effect of dexmedetomidine during total intravenous anesthesia for children undergoing dental surgery: A randomized controlled trial

Authors:

Victor CL Lee et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: